Femasys (FEMY) Return on Equity [ROE] (2021 - 2026)
Femasys (FEMY) reported Return on Equity [ROE] of -354.67% for Q2 2026, up 844.79 percentage points from -1199.45% a year earlier.
Powered by 
Analysis
Femasys (FEMY) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Femasys posted Return on Equity [ROE] of -455.80%, down 273.62 percentage points from FY2024.
- Return on Equity [ROE] has declined for three consecutive years, with a three-year change of -400.99 percentage points (FY2022 to FY2025).
- By year, Return on Equity [ROE] came in at -182.18% in FY2024 (-97.36 pp), -84.82% in FY2023 (-30.00 pp) and -54.81% in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q3 2024.
- Year over year, Return on Equity [ROE] gained in 1 of the last five quarters, with an average year-over-year change of -315.78 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2026 (a gain of 844.79 percentage points); the low point was Q2 2025 (a drop of 1075.16 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 267.71 Bn | 244.23 Bn | 5.13 Bn | 13.20% |
| 2 | Abbott Laboratories | 191.69 Bn | 165.56 Bn | 7.39 Bn | 9.09% |
| 3 | Danaher | 166.18 Bn | 145.83 Bn | 3.84 Bn | 8.15% |
| 4 | Intuitive Surgical | 161.07 Bn | 141.36 Bn | 2.08 Bn | 17.28% |
| 5 | Medtronic | 131.65 Bn | 96.90 Bn | 6.34 Bn | 10.44% |
| 6 | Stryker | 125.25 Bn | 111.44 Bn | 4.25 Bn | -4.01% |
| 7 | Boston Scientific | 63.85 Bn | 59.29 Bn | 3.43 Bn | 13.69% |
| 8 | Edwards Lifesciences | 60.52 Bn | 43.72 Bn | 1.35 Bn | 9.36% |
| 9 | Becton Dickinson | 59.08 Bn | 56.23 Bn | 2.32 Bn | 3.88% |
| 10 | Femasys | 4.87 Mn | -15.80 Mn | 189,391.00 | -354.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -354.67% |
| Jun 30, 2025 | -1,199.45% |
| Mar 31, 2025 | -981.78% |
| Dec 31, 2024 | -454.83% |
| Sep 30, 2024 | -210.26% |
| Jun 30, 2024 | -124.29% |
| Mar 31, 2024 | -87.75% |
| Dec 31, 2023 | -99.63% |
| Sep 30, 2023 | -110.96% |
| Jun 30, 2023 | -95.15% |
| Mar 31, 2023 | -85.30% |
| Dec 31, 2022 | -69.86% |
| Sep 30, 2022 | -56.36% |
| Jun 30, 2022 | -45.78% |
| Mar 31, 2022 | -34.49% |
| Dec 31, 2021 | -27.42% |
| Sep 30, 2021 | -22.95% |
API Access
Femasys Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=FEMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "FEMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=FEMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();